| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/30/2008 | CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides |
| 12/30/2008 | CA2132349C Chimeric receptor genes and cells transformed therewith |
| 12/30/2008 | CA2113744C Methods for regulating the immune response using ctla4-binding molecules and il4-binding molecules |
| 12/25/2008 | US20080319082 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives |
| 12/25/2008 | US20080319078 Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators |
| 12/25/2008 | US20080319066 Jasmonate Derivative Compounds, Pharmaceuticals Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319061 Process for the Preparation of an Oxaliplatin Preparation |
| 12/25/2008 | US20080319054 Treatment of Cancer |
| 12/25/2008 | US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/25/2008 | US20080319048 Solubilized formulation of docetaxel without tween 80 |
| 12/25/2008 | US20080319045 Combination of Histone Deacetylase Inhibitors and Radiation |
| 12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319039 Unit dosage forms of temozolomide |
| 12/25/2008 | US20080319037 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors |
| 12/25/2008 | US20080319031 Novel Tyrosine Derivatives |
| 12/25/2008 | US20080319012 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 12/25/2008 | US20080319011 Protein tyrosine kinase enzyme inhibitors |
| 12/25/2008 | US20080319001 Cancer Treatment Using Specific 3,6,9-Substituted Acridines |
| 12/25/2008 | US20080318998 Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines |
| 12/25/2008 | US20080318995 N-Substituted Indenoisoquinolines and Syntheses Thereof |
| 12/25/2008 | US20080318989 Pyrimidine Kinase Inhibitors |
| 12/25/2008 | US20080318988 Pyrimidylaminobenzamide Derivatives For the Treatment of Neurofibromatosis |
| 12/25/2008 | US20080318983 A2b adenosine receptor antagonists |
| 12/25/2008 | US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS |
| 12/25/2008 | US20080318974 Such as 1-[2-(piperidin-3-ylmethoxy)-5-trifluoromethyl-phenyl]-3-(5-trifluoromethyl-pyrazin-2-yl)-urea hydrochloride salt; checkpoint kinase (Chk1) inhibitors; cancer; diseases characterized by defects in DNA replication, chromosome segregation and/or cell division |
| 12/25/2008 | US20080318971 using bosutinib |
| 12/25/2008 | US20080318960 PAR2-modulating compounds and their use |
| 12/25/2008 | US20080318950 Quinazoline Derivatives as a Multiplex Inhibitor and Method For the Preparation Thereof |
| 12/25/2008 | US20080318947 Inhibitors of Akt Activity |
| 12/25/2008 | US20080318946 Di-amino-substituted heterocyclic compounds and methods of use |
| 12/25/2008 | US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 12/25/2008 | US20080318942 Fredericamycin Derivatives |
| 12/25/2008 | US20080318938 Methods for treating aberrant cell proliferation disorders |
| 12/25/2008 | US20080318936 Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines |
| 12/25/2008 | US20080318928 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof |
| 12/25/2008 | US20080318924 Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same |
| 12/25/2008 | US20080318907 Nitroxide Free Radical Synergized Antineoplastic Agents |
| 12/25/2008 | US20080318906 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| 12/25/2008 | US20080318903 Methods for treating cancer |
| 12/25/2008 | US20080318891 Antisense oligonucleotides against thymidylate synthase |
| 12/25/2008 | US20080318890 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/25/2008 | US20080318889 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/25/2008 | US20080318888 Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/25/2008 | US20080318887 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 12/25/2008 | US20080318886 Methods of Increasing Cancer Sensitivity to Chemotherapeutic Agents Using Chimeric ISF35 |
| 12/25/2008 | US20080318880 Neoadjuvant treatment of Breast Cancer |
| 12/25/2008 | US20080318879 Method for the Preparation of Polymeric Conjugates of Doxorubicin with Ph-Controlled Release of the Drug |
| 12/25/2008 | US20080318875 Core 2 Glcnac-T Inhibitors |
| 12/25/2008 | US20080318873 Camptothecin derivatives as chemoradiosensitizing agents |
| 12/25/2008 | US20080318864 Methods and compositions regarding polychalcogenide compositions |
| 12/25/2008 | US20080318855 Dna encoding for recombinant polypeptide emutants of human stromal cell-derived factor 1 |
| 12/25/2008 | US20080318849 Kahalalide F and Related Compounds |
| 12/25/2008 | US20080318848 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; anticarcinogenic agent; refractory cancer that does not respond favorably to other treatments; peptides isolated mollusc, Elysia Elysia rufescens and its diet, a green algae |
| 12/25/2008 | US20080318846 Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 12/25/2008 | US20080318844 Composition and method for the treatment of diseases affected by histone deacetylase inhibitors |
| 12/25/2008 | US20080318840 Compositions of Alpha-Fetoprotein and Inducers of Apoptosis for the Treatment of Cancer |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318836 sCD Fingerprints |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080318253 Monoclonal anti-idiotypic antibody; antitumor agents; anticarcinogenic agents; antiproliferative agents; immunotherapy; hormone antagonist therapy |
| 12/25/2008 | US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis |
| 12/25/2008 | US20080317870 Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D |
| 12/25/2008 | US20080317767 Tripartitle Raftophilic Strutures and their Use |
| 12/25/2008 | US20080317760 Compositions and Methods for Diagnosing and Treating Cancer |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317755 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317753 Selecting patients for therapy with a her inhibitor |
| 12/25/2008 | US20080317752 Inhibition of Tumorigenesis by Inhibition of a6b4 Integrin |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317747 Recombinant anti-cd30 antibodies and uses thereof |
| 12/25/2008 | US20080317746 Anti-Il2 Antibodies |
| 12/25/2008 | US20080317745 Methods of diagnosing, treating, or preventing plasma cell disorders |
| 12/25/2008 | US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction |
| 12/25/2008 | US20080317729 Ammonium Salts and Ammonium Salt/Mineral Salt Clathrate Compounds for Use as Vehicle and Effective Form for Pharmaco-Medical Applications and for Use as Phase Transfer Agents for Chemical Applications |
| 12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
| 12/25/2008 | US20080317709 Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 12/25/2008 | US20080317708 Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3dione |
| 12/25/2008 | US20080317667 Compositions and methods for inhibiting growth of smad4-deficient cancers |
| 12/24/2008 | WO2008157776A2 Modified diphtheria toxins |
| 12/24/2008 | WO2008157575A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 12/24/2008 | WO2008157272A2 Deuterium-enriched tamsulosin |
| 12/24/2008 | WO2008157211A1 Crystalline forms of (3aalpha,4beta,5alpha,7beta,7aalpha)-4-(octahydro-5-ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,-7-ep0xy-2h-isoind0l-2-yl)- |
| 12/24/2008 | WO2008157191A2 Quinazoline derivatives as pi3 kinase inhibitors |
| 12/24/2008 | WO2008157003A2 Chemical inhibitors of bfl-1 and related methods |
| 12/24/2008 | WO2008156739A1 Heterocyclic compounds and use thereof as erk inhibitors |
| 12/24/2008 | WO2008156713A2 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | WO2008156712A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | WO2008156642A1 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 12/24/2008 | WO2008156629A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 12/24/2008 | WO2008156614A2 Imidazopyrazines as protein kinase inhibitors |
| 12/24/2008 | WO2008156460A1 Bioconjugated nanoparticles |
| 12/24/2008 | WO2008156172A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008156012A1 CANCER REMEDY CONTAINING MORTALIN siRNA |
| 12/24/2008 | WO2008155920A1 Drug having effect of promoting hepatocyte growth |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155727A1 Platinum (iv) complexes |